Made by Popular Pharmaceuticals Ltd., Benozol is a ophthalmic suspension whose active ingredient is Brinzolamide. It may be prescribed as the only medicine for eye pressure or as an add-on to beta-blocker ophthalmic suspension.
There are 13 brands of Brinzolamide listed in Bangladesh. 7 of them have a lower unit price than Benozol. The lowest listed price is Ocubrin 10 mg/ml Eye Drops at ৳ 500.00 per unit.
What is Benozol 1% Ophthalmic Suspension?
The ophthalmic suspension Benozol contains Brinzolamide and is made by Popular Pharmaceuticals Ltd. Benozol 1% ophthalmic suspension is a prescription eye drop with the active ingredient Brinzolamide. It can be used alone or alongside other eye pressure medicines such as beta-blockers. The doctor decides the dose and course.
Uses of Benozol
It may be prescribed as the only medicine for eye pressure or as an add-on to beta-blocker ophthalmic suspension. Lowering eye pressure helps reduce the risk of further damage to the eye. Benozol ophthalmic suspension are used to treat elevated intraocular pressure in adults with ocular hypertension or open-angle glaucoma. Your doctor will decide if it is suitable for you.
How to use Benozol
Shake the bottle well before each use. Measure the liquid with the spoon or cap that comes with the pack. Swallow the ophthalmic suspension as advised. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.
Side effects of Benozol
If you experience any side effect that worries you, or if it does not go away, speak to your doctor or pharmacist. Reported side effects are blurred vision and bitter, sour or unusual taste. Other side effects are blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia, ocular discharge, ocular discomfort, ocular keratitis, ocular pain, ocular pruritus and rhinitis. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
The concomitant administration of Brinzolamide ophthalmic suspension and oral carbonic anhydrase inhibitor is not recommended due to no additional benefits. Brinzolamide ophthalmic suspension and its metabolite are excreted predominantly by the kidney. Brinzolamide ophthalmic suspension has not been studied in patients with hepatic impairment and should be used with caution in such patients. Keep out of reach of children.
Frequently asked questions
Why is Benozol prescribed?
It may be prescribed as the only medicine for eye pressure or as an add-on to beta-blocker ophthalmic suspension. Lowering eye pressure helps reduce the risk of further damage to the eye.
How do I use Benozol correctly?
Shake the bottle well before each use. Measure the liquid with the spoon or cap that comes with the pack.
What should I watch for while using Benozol?
If you experience any side effect that worries you, or if it does not go away, speak to your doctor or pharmacist. Reported side effects are blurred vision and bitter, sour or unusual taste.
Brinzolamide Ophthalmic Suspension is indicated as monotherapy, or as adjunctive therapy to beta-blockers in the treatment of elevated intraocular pressure in ocular hypertension, or open-angle glaucoma.
Pharmacology
Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. It catalyses the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. It exists as a number of isoenzymes, the most active being carbonic anhydrase II (CA-II), found primarily in red blood cells, but also in other tissues. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fuid transport.
Following topical ocular administration, brinzolamide inhibits aqueous humor formation and reduces elevated intraocular pressure. Elevated intraocular pressure is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual feld loss.
Dosage & Administration
The recommended dose is one drops of this eye drop in the conjunctival sac of the affected eye(s) twice daily. Some patients may have a better response with one drop three times a day. Shake well before use.
Interaction
In patients treated with oral carbonic anhydrase inhibitors, rare instances to drug interactions have occurred with high-dose salicylate therapy. Therefore, the potential for such drug interactions should be considered in patients receiving Brinzolamide.
Contraindications
It is contraindicated in patients who are hypersensitive to any component of this product.
Side Effects
Reported side effects are blurred vision and bitter, sour or unusual taste. Other side effects are blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia, ocular discharge, ocular discomfort, ocular keratitis, ocular pain, ocular pruritus and rhinitis.
Pregnancy & Lactation
Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Brinzolamide 1% ophthalmic suspension should be used during pregnancy only if the benefit justifies the potential risk to the fetus.
Use in lactation: It is not known whether Brinzolamide 1% ophthalmic suspension is excreted in human milk. So, lactating mother should discontinue nursing or to discontinue the drug, depending upon the importance of the drug to the mother.
Precautions & Warnings
Brinzolamide ophthalmic suspension and its metabolite are excreted predominantly by the kidney. So, it is not recommended in severe renal impaired patients.
Brinzolamide ophthalmic suspension has not been studied in patients with hepatic impairment and should be used with caution in such patients.
The concomitant administration of Brinzolamide ophthalmic suspension and oral carbonic anhydrase inhibitor is not recommended due to no additional benefits.
If hypersensitivity reaction occurs after instillation patients should be advised to discontinue the use of Brinzolamide and consult with physicians.
Overdose Effects
Although no human data are available, electrolyte imbalance, development of an acidosis state, and possible nervous system effects may occur following oral administration of an overdose. Serum electrolyte levels (particularly potassium) and blood pH levels should be monitored.
Storage Conditions
Store at room temperature & protect from light. Do not touch dropper tip to any surface. It is desirable that the contents should not be used more than four weeks after first opening of the bottle. Protect from freezing.
Alternative brands of Brinzolamide
Other brands with the same generic name, cheapest first.